Institutional shares held 15.6 Million
67.6K calls
60.9K puts
Total value of holdings $34.6M
$150K calls
$135K puts
Market Cap $80.2M
36,145,300 Shares Out.
Institutional ownership 43.08%
# of Institutions 39


Latest Institutional Activity in EDAP

Top Purchases

Q3 2024
Parkman Healthcare Partners LLC Shares Held: 155K ($344K)
Q3 2024
Rock Springs Capital Management LP Shares Held: 1.57M ($3.48M)
Q3 2024
Schonfeld Strategic Advisors LLC Shares Held: 108K ($240K)
Q3 2024
Summit Trail Advisors, LLC Shares Held: 60K ($133K)
Q3 2024
Accredited Investors Inc. Shares Held: 21.4K ($47.6K)

Top Sells

Q3 2024
Federated Hermes, Inc. Shares Held: 288K ($640K)
Q3 2024
Archon Capital Management LLC Shares Held: 1.06M ($2.36M)
Q3 2024
Susquehanna International Group, LLP Shares Held: 42K ($93.3K)
Q3 2024
Group One Trading, L.P. Shares Held: 5.35K ($11.9K)
Q3 2024
Morgan Stanley Shares Held: 3.37M ($7.48M)

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.


Insider Transactions at EDAP

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on EDAP

Follow EDAP TMS SA and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDAP shares.

Notify only if

Insider Trading

Get notified when an Edap Tms Sa insider buys or sells EDAP shares.

Notify only if

News

Receive news related to EDAP TMS SA

Track Activities on EDAP